National Guideline Clearinghouse | Breast cancer follow-up and management after primary treatment: A Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology cl ...
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Soci 1. J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists ...
R SCREENING Breast Cancer Screening | September 2013 Clinical Practice Guideline Page 4 of 14 Background Follow recommendations from Medical Genetics regarding screening and risk reduction. For eligible women who decline or are unable to attend counseling, follow the
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society Results This guideline update reflects emerging data on duration of tamoxifen treatment. There have been five studies of tamoxifen treatment beyond 5 years of therapy. The two largest studies with longest reported follow-up show a breast cancer ...
Familial breast cancer | Guidance and guidelines | NICE Familial breast cancer: Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family ... This clinical guideline updates and replaces NICE clinical guideline 41 (published in
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice ...
NCCN Guidelines and Compendium Updated - National ... *For your reference, the announcement of the previous update (Version 1.2013) to the NCCN Guidelines for Breast Cancer, distributed on February 6, 2013, ...
About NCCN - National Comprehensive Cancer Network The May 23, 2013 Oncology Tumor Board will focus on triple negative breast ... In the NCCN Guidelines®, systemic chemotherapy is often recommended to ...
(NCCN Guidelines®) Breast Cancer The NCCN Guidelines and this illustration may not be reproduced in any form without the ... Printed by kong tiandong on 2/21/2013 4:34:08 AM. .... the 1.2013 version of the NCCN Guidelines for Breast Cancer from the 3.2012 version include:.
NCCN Clinical Practice Guidelines in Oncology - The ASCO Post 15 May 2014 ... Breast Cancer Guidelines Incorporate Pertuzumab. The 2014 NCCN Guidelines now recommend the addition of .... In multiple myeloma, it seems that “more is better,” as studies reported in 2013 support the concept of ...